In order to control health care costs, urologists are being urged to review diagnostic and therapeutic procedures. A review was made of some diagnostic choices and alternative therapies for benign prostatic hypertrophy, which is the most frequently encountered pathology in clinical practice. Despite the numerous methods in being, transurethral resection of the prostate is still the gold standard in the treatment of this pathology at an acceptable cost-benefit ratio.
LitwinM.S.KahnK.L.RecciusN.: Why do sicker patients cost more? A charge-based analysis of patients undergoing prostatectomy. J. Urol., 149: 84–88, 1993.
2.
EpsteinA.M.SternR.S.TognettiJ.BeggC.B.HartleyR.M.CumellaE.Jr.AyanianJ.Z.: The association of patients’ socioeconomic characteristics with the length of hospital stay and hospital charges within diagnosis-related groups. N. Eng. J. Med., 318: 1579–1585, 1988.
LottoA.OlivoG.ComunaleL.MalossiniG.: L'indispensabile, l'utile e il superfluo nella terapia endoscopies dell'ipertrofia prostatica benigna e del carcinoma della prostata. Atti del Convegno su: L'indispensabile, l'utile e il superfluo: analisi critica del chirurgo al proprio lavoro.Verona, Grafiche Fiorini, pp. 171–186, 1996.
5.
MebustW.K.: Prostatectomia transuretrale. In: La Prostata. Edito da FitzpatrickJ.M.KraneR.J., Verducci Editore Roma, cap. 17: 141–147, 1992.
6.
KockM.O.SmithJ.A.Jr.: Cost containment in uro-i logy. Urology, 46: 14–26: 1995.
FiorettiC.MenghettiI.RazmjoueiK.MacchiarellaA.CelsoM.: Il trattamento alternativo della ipertrofia prostatica benigna. Minerva Urol. Nefrol., 48: 177–182, 1996.
9.
ZlottaA.R.PenyM.O.MatosC.SchullnanC.C.: Transurethral needle ablation of the prostate: clinical experience in patients in urinary acute retention. Br. J. Urol., 77: 391–397, 1996.
10.
KaplanS.A.TeA.E.: A comparative study of transurethral resection of the prostate using a modified electro-vaporizing loop and transurethral laser vaporization of the prostate. J. Urol., 154: 1785–1790, 1995.
11.
MarbergerM.: Benign prostatic hyperplasia (BPH) therapy: when? how? why? the take-home message. J. Urol., Paris101: 56–57, 1995.
12.
DixonC.M.: Evaluating the efficacy, safety and cost of laser for the treatment of benign prostatic hyperplasia. World J. Urol., 13: 130–133, 1995.
13.
ValeJ.A.BdeshaA.S.WitherowR. O'N.: An analysis of the costs of alternative treatments for benign prostate hypertrophy. J. R. Soc. Med., 88: 644–648, 1995.
14.
HartungR.: Transurethral prostatectomy (TURP): still the gold standard? J. Urol. (Paris), 101: 18–21, 1995.
15.
PatelA.: Prostata e ipertrofia prostatica benigna. In: 1996 Year Book di Urologia.Edito da DeKernionJ.B.HowardsS.S., Bayer Torino, cap. 20: 177, 1997.
16.
EdwardsL.: Incisione transuretrale della prostata o incisione del collo vescicale. In: La prostata.Edito da FitzpatrickJ.M.KraneR.J., Verducci Editore Roma, cap. 30: 223–227, 1992.
